AUROPHARMA

AUROBINDO PHARMA ; GETS USFDA APPROVAL FOR NICHE DRUG 💊 • 🇺🇸 Receives USFDA approval for Glycerol Phenylbutyrate Oral Liquid (1.1 g/mL) • ⚕️ Used for treatment of urea cycle disorders (rare disease) • 🚀 Product to be launched immediately, manufactured at Unit-III • 💰 Estimated market size ~$50 Mn (IQVIA data) • 📊 Total ANDA approvals now at 579 (556 final + 23 tentative) 🟢 Impact: Positive (USFDA approval + niche product + strengthens US generics portfolio)